AddSino Co., Ltd. (000547.SZ) issued a forecasted loss, expecting a net loss of 1.63 billion to 1.83 billion yuan for the year 2024.
Space Development (000547.SZ) released its 2024 performance forecast, expecting the 2024 attributable....
Addsino Co., Ltd. (000547.SZ) announced its performance forecast for the year 2024, expecting a net loss attributable to shareholders of the listed company of 16.3 billion to 18.3 billion. The main reasons are: affected by market cyclic fluctuations, delays in customer bidding projects, among other factors, the company's new contract volume fell short of expectations, coupled with stricter quality requirements, continuing cost increases, leading to insufficient revenue and gross profit; some urgent safeguard tasks did not cover the corresponding expenses; performance of some subsidiaries was affected by project appraisal; important equity investee companies continue to incur substantial losses; and due to factors such as lower-than-expected receipts, the company made impairment provisions for related assets with possible impairment losses.
Related Articles

SILKWAVE INC (00471) completed the issuance of 19,063,900 subscription shares.

Biogen (BIIB.US) plans to acquire Alcyone to expand drug delivery solutions.
Low-cost military technology demand surges, small and medium-sized defense stocks in the US outperform the S&P 500 and military giants within the year.
SILKWAVE INC (00471) completed the issuance of 19,063,900 subscription shares.

Biogen (BIIB.US) plans to acquire Alcyone to expand drug delivery solutions.

Low-cost military technology demand surges, small and medium-sized defense stocks in the US outperform the S&P 500 and military giants within the year.
RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025